| For: | Ma W, Baran N. Expanding horizons in esophageal squamous cell carcinoma: The promise of induction chemoimmunotherapy with radiotherapy. World J Clin Oncol 2025; 16(7): 104959 [PMID: 40741200 DOI: 10.5306/wjco.v16.i7.104959] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i7/104959.htm |
| Number | Citing Articles |
| 1 |
Kai Yang, Wei Shang, Lu Wang, Jianzhong He, Zhigang Zuo, Quankai Dai, Jialing Liu, Langhong Zeng, Yuntian Yang, Fengjun Cao, Yuandong Yu, Guoxing Wan. Sex-based heterogeneity in response to first-line immunotherapy plus chemotherapy in advanced esophageal squamous-cell carcinoma: a meta-analysis. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1784688
|
| 2 |
Xuejun Guo, Shuhan Ma, Jingwen Wang, Yilin Fu, Wenxue Ma. Terminally exhausted CD8+ T cells in solid tumors: biology, biomarker potential and translational tools for precision oncology. Frontiers in Immunology 2026; 16 doi: 10.3389/fimmu.2025.1709852
|
| 3 |
Yi Gan, Yue Li, Li Fang, Yuejun Chen, Desong Yang. Survival benefit and dynamics of CD8+ T cells and tumor-associated macrophages in neoadjuvant immunochemotherapy vs. chemotherapy for locally advanced esophageal squamous cell carcinoma: an IPTW-adjusted real-world study. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1788756
|
| 4 |
Shubhankar Dash, Patryk Firmanty, Monika Chomczyk, Vakul Mohanty, Wenxue Ma, Natalia Baran. Targeting MDSCs in cancer: emerging immunotherapeutic and metabolic strategies. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1749965
|
